PLAY PODCASTS
Podcast on On-Demand PrEP: Strategies to Support PrEP Persistence and Reengagement
Episode 352

Podcast on On-Demand PrEP: Strategies to Support PrEP Persistence and Reengagement

Hear from Jean-Michel Molina, MD, PhD, in this case-based discussion of the data and recommendations for considering on-demand PrEP as a strategy to support PrEP persistence and engagement for men who have sex with men.

Decera Clinical Education Infectious Disease Podcast · Jean Michel Molina MD PhD

November 30, 202315m 6s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Jean-Michel Molina, MD, PhD, discusses the data and recommendations for considering on-demand PrEP as a strategy to support PrEP persistence and engagement for men who have sex with men, including:

  • Nondaily PrEP options recommended for cisgender men
  • Data from the ANRS IPERGAY study evaluating on-demand FTC/TDF vs placebo in men who have sex with men
  • Real-world data on the effectiveness of on-demand PrEP
  • Considerations for on-demand FTC/TDF in people with renal dysfunction
  • Data on hypertension and statin initiation risk with FTC/TAF PrEP
  • Data on weight gain with the different PrEP options

Faculty

Jean-Michel Molina, MD, PhD
Professor of Infectious Diseases
University of Paris Cité
Head of the Department of Infectious Diseases
Hospital Saint-Louis and Lariboisière
Paris, France

Follow along with the slides
https://bit.ly/47VGZVL

Link to full program:
https://bit.ly/3ZlICsL


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

renal functioncohmsm-prepcabotegravirpersistencehypertensionevent-drivennondailycabprévenir2-1-1on-demandjean-michel molinapreexposure prophylaxisprepcroprepweight gainemtricitabineengagementftc/tdfstatin initiationftc/tafadherencetenofoviripergay